- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT03251391
Cardiac Rehabilitation Program in Peripheral Arterial Disease
To Assess the Safety and Feasibility of a Structured Cardiac Rehabilitation Program in Patients With Peripheral Arterial Disease After Successful Revascularization Procedures: A Pilot Study.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Kansas
-
Kansas City, Kansas, Estados Unidos, 66160
- University Of Kansas Medical Center
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Patients with PAD post-revascularization (stent, angioplasty, or bypass).
- Patients must have the ability to ambulate safely without assistance and should not have plans for undergoing further staged revascularization procedures.
Exclusion Criteria:
- Below or above the knee amputation.
- Underlying cardiopulmonary or other co-morbidity that would be an exclusion under currently approved standard CR protocols at the University of Kansas Medical Center (KUMC).
- Unfavorable short term prognosis and limited life expectancy (<2 years)
- Awaiting a planned staged revascularization in same or other leg (patients will be eligible once no further procedures are planned).
- Prior history of having dropped out of CR without completing.
- Unwilling to consent for all aspects of CR or study participation.
- Unable to come for CR (this will exclude patients who live far away or have no means to travel to the CR facility).
- Pregnancy
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: No aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
---|---|
Experimental: Cardiac Rehabilitation Group
Participants randomized to this group will undergo cardiac rehabilitation program.
|
Program will involve 36 sessions. These will be scheduled as 3 sessions per week. If you cannot complete 3 sessions per week the 36 sessions could be spread out over 6 months. Each session will last between 30-60 minutes. Sessions will involve aerobic activity, diet/nutritional counseling, and smoking cessation information. |
Comparador activo: Control Group
Participants randomized to this group will receive care for their condition, conventional therapy, that they would normally receive.
|
Participants will be asked to complete tests and questionnaires that would normally be done for their condition.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Change in 6 minute walk test
Periodo de tiempo: Change from Baseline to Up to 6 Months
|
Results will be measured in meters.
|
Change from Baseline to Up to 6 Months
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Short Form Health Survey 36 (SF-36)
Periodo de tiempo: Change from Baseline to Up to 6 Months
|
Change in quality of life measured using the SF-36.
The survey has 36 questions and measure eight health dimensions.
The scores range from 0-100.
A higher score represents less disability.
A lower score represents more disability.
|
Change from Baseline to Up to 6 Months
|
Short Form Health Survey 36 (SF-36)
Periodo de tiempo: Change from Baseline to Week 18
|
Change in quality of life measured using the SF-36.
The survey has 36 questions and measure eight health dimensions.
The scores range from 0-100.
A higher score represents less disability.
A lower score represents more disability.
|
Change from Baseline to Week 18
|
Vascular Quality of Life Questionnaire-6 (VascuQol6)
Periodo de tiempo: Change from Baseline to Up to 6 Months
|
The six-item Vascular Quality of Life (VascuQol-6) is a valid, practical, and responsive instrument for the assessment of health-related QOL in patients with PAD. The main advantage is the compact format that offers a possibility for routine use in busy clinical settings. Range of scores and what they represent: Each question is scored 1-4. The total score is achieved by summarizing the score on each question, resulting in a score between 6 and 24. Higher value indicates better health status. |
Change from Baseline to Up to 6 Months
|
Vascular Quality of Life Questionnaire-6 (VascuQol6)
Periodo de tiempo: Change from Baseline to Week 18
|
The six-item Vascular Quality of Life (VascuQol-6) is a valid, practical, and responsive instrument for the assessment of health-related QOL in patients with PAD. The main advantage is the compact format that offers a possibility for routine use in busy clinical settings. Range of scores and what they represent: Each question is scored 1-4. The total score is achieved by summarizing the score on each question, resulting in a score between 6 and 24. Higher value indicates better health status. |
Change from Baseline to Week 18
|
Absolute Claudication Distance (ACD)
Periodo de tiempo: Change from Baseline to Up to 6 Months
|
ACD is defined as the walking distance after which a patient had to stop walking to relieve claudication pain.
Distance is measured in meters
|
Change from Baseline to Up to 6 Months
|
Functional Claudication Distance (FCD)
Periodo de tiempo: Change from Baseline to Up to 6 Months
|
FCD is defined as the distance a patient would prefer to stop because of claudication pain.
Distance is measured in meters.
|
Change from Baseline to Up to 6 Months
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Kamal Gupta, MD, University Of Kansas Medical Center
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- STUDY00140692
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
producto fabricado y exportado desde los EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Enfermedad arterial periférica
-
Dartmouth-Hitchcock Medical CenterDartmouth CollegeTerminadoPresión arterial | Anestesia | Línea ArterialEstados Unidos
-
Auburn UniversityActivo, no reclutandoDormir | Presión arterial | Disfunción endotélica | Racismo | Rigidez ArterialEstados Unidos
-
AHEPA University HospitalTerminadoRigidez arterial | Monitoreo ambulatorio de la presión arterialGrecia
-
Unity Health TorontoTerminadoRigidez arterial, presión arterialCanadá
-
CID S.p.A.Meditrial Europe Ltd.Aún no reclutandoEnfermedad arterial periférica oclusiva | Enfermedad Arterial PeriféricaItalia
-
Marissa JarosinskiReclutamientoEnfermedad arterial periférica oclusiva | Enfermedad vascular periférica | Enfermedad Arterial Periférica | Clopidogrel, metabolismo deficiente de | Enfermedad ArterialEstados Unidos
-
ROX Medical, Inc.TerminadoHipertensión | Presión Arterial, Alta | Presión Arterial, Resistente | Presión Arterial, No ControladaReino Unido, Países Bajos, Bélgica
-
Istituto Auxologico ItalianoReclutamientoHipertensión arterial | Monitoreo ambulatorio de la presión arterial | Determinación de la presión arterial | Monitoreo de la presión arterial en el hogarItalia
-
University of JyvaskylaBusiness Finland; Finnish Foundation for Cardiovascular Research; Harvia Finland...TerminadoPresión arterial | Factor de riesgo cardiovascular | Rigidez arterialFinlandia
-
University of NebraskaAún no reclutandoEnfermedad arterial periférica | Enfermedades vasculares periféricas | Enfermedad arterial periférica oclusiva | Enfermedad Arterial PeriféricaEstados Unidos
Ensayos clínicos sobre Cardiac Rehabilitation Program
-
University Hospital, LinkoepingLinkoeping University; Ryhov County HospitalDesconocido
-
IWK Health CentreCanadian Institutes of Health Research (CIHR)TerminadoTrastorno de ansiedadCanadá
-
Akdeniz UniversityAún no reclutandoAccidente cerebrovascular isquémico | EntrenamientoPavo
-
The University of Hong KongSydney Children's Hospitals Network; SAHKReclutamientoDesorden del espectro autistaHong Kong
-
Children's HealthActivo, no reclutandoDesorden del espectro autistaEstados Unidos
-
St. Luke's-Roosevelt Hospital CenterTerminado
-
University of KonstanzWorld BankDesconocidoTrastorno de estrés postraumático | Agresión apetitivaCongo
-
Medtronic Cardiac Rhythm and Heart FailureTerminadoInsuficiencia cardíaca congestivaEstados Unidos
-
Medtronic Bakken Research CenterTerminadoInsuficiencia cardiacaPaíses Bajos
-
Respicardia, Inc.TerminadoApnea del sueño | Respiración desordenada del sueño | Respiración periódica | Apnea central del sueño | Respiración de Cheyne StokesEstados Unidos, Polonia, Alemania, Italia